Dyne Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $165.1M
Liabilities Breakdown FY2023
Total Liabilities: $73.8M
Asset Breakdown
Total Assets: $165.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $121.6M | 73.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.8M | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $38.7M | 23.4% |
Liabilities Breakdown
Total Liabilities: $73.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $22.9M | 31.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $50.9M | 68.9% |